Genetically Engineered T-Cells Force Leukemia into Remission

A pretty amazing story indeed……13 people with a form of cancer called multiple myeloma were treated with genetically engineered T-Cells and all 13 are now in remission or close to it.  “The fact we got a response in all 13, you can’t get better than that,” says James Noble, CEO of Adaptimmune in Abingdon, UK, which developed the treatment.

The T-Cells can better recognise proteins called NY-ESO-1 and LAGE-1, these are found on myeloma cells only.  All 13 showed a boost in their white blood cell count.

We all probably know someone that has been taken b/c of cancer or is currently struggling with it.  It seems as though science has really made major strides in battling it, and we hope to hear more good news from this study after they’ve gone through additional trials.

Read more over at NewScientist.com

You may also like

Legislative panel approves medical malpractice bill
Read more
Urgent-care centers: Illinois numbers grow as time-pressed families seek low-cost option to ERs
Read more
Global Center for Medical Innovation launches
Read more

Recent Posts

California Healthcare Providers, Trial Attorneys, Legislators Reach Deal to Increase MICRA Cap

Corporate Acquisitions Accelerating Surge in Employed Physicians

AM Best Maintains Negative Outlook for MPL Segment in 2022, Cites Rising Loss Costs, Increasing Severity, Diminished Reserves

Popular Posts

PIAA 2017: Current Trends & Future Concerns

New Report: Best and Worst States for Doctors

Urgent-care centers: Illinois numbers grow as time-pressed families seek low-cost option to ERs

Start Your Custom Quote Process™

Request a free quote